These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6445202)

  • 1. Acne vulgaris: is the bacterial population size significant?
    Cove JH; Cunliffe WJ; Holland KT
    Br J Dermatol; 1980 Mar; 102(3):277-80. PubMed ID: 6445202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intergeneric and intrageneric inhibition between strains of Propionibacterium acnes and micrococcaceae, particularly Staphylococcus epidermidis, isolated from normal skin and acne lesions.
    Holland KT; Cunliffe WJ; Eady EA
    J Med Microbiol; 1979 Feb; 12(1):71-82. PubMed ID: 34728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
    Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
    Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acne vulgaris: an investigation into the number of anaerobic diphtheroids and members of the Micrococcaceae in normal and acne skin.
    Holland KT; Cunliffe WJ; Roberts CD
    Br J Dermatol; 1977 Jun; 96(6):623-6. PubMed ID: 141301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
    Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
    J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of Cutibacterium acnes phylotypes in acne and in vivo exploratory evaluation of Myrtacine
    Pécastaings S; Roques C; Nocera T; Peraud C; Mengeaud V; Khammari A; Dréno B
    J Eur Acad Dermatol Venereol; 2018 Jun; 32 Suppl 2():15-23. PubMed ID: 29894577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution to the interpretation of the occurrence of unsuccessful therapeutical results in acne vulgaris with topical erythromycin (Propionibact. acnes).
    Gloor M; Lamerz A; Franke-Hoffman M
    Zentralbl Bakteriol A; 1981 Feb; 248(4):502-8. PubMed ID: 6452774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetracycline-resistant staphylococci in acne vulgaris.
    Shalita AR; Rosenthal SA
    Acta Derm Venereol; 1972; 52(1):64-6. PubMed ID: 4111110
    [No Abstract]   [Full Text] [Related]  

  • 9. [Characteristics of the Propionibacterium strains isolated from acne patients].
    Białecka A; Kasprowicz A; Kaszycki P; Marcinkiewicz J
    Med Dosw Mikrobiol; 2004; 56(1):79-92. PubMed ID: 15524399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents.
    Nishijima S; Kurokawa I; Kawabata S
    J Int Med Res; 1996; 24(6):473-7. PubMed ID: 8959531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris.
    Kurokawa I; Nishijima S; Kawabata S
    Eur J Dermatol; 1999; 9(1):25-8. PubMed ID: 9920982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the propionibacteria in the pilosebaceous ducts of uninvolved skin of acne patients.
    Gloor M; Franke M
    Arch Dermatol Res; 1978 Jun; 262(1):125-9. PubMed ID: 150822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial resistance in French acne patients.
    Dumont-Wallon G; Moyse D; Blouin E; Dréno B
    Int J Dermatol; 2010 Mar; 49(3):283-8. PubMed ID: 20465665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of acne vulgaris: recent advances.
    Bhambri S; Del Rosso JQ; Bhambri A
    J Drugs Dermatol; 2009 Jul; 8(7):615-8. PubMed ID: 19588637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris.
    Giannopoulos L; Papaparaskevas J; Refene E; Daikos G; Stavrianeas N; Tsakris A
    Anaerobe; 2015 Feb; 31():50-4. PubMed ID: 25451716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the mechanism of action of 2% fusidic acid lotion in the treatment of acne vulgaris.
    Sommer S; Bojar R; Cunliffe WJ; Holland D; Holland KT; Naags H
    Clin Exp Dermatol; 1997 Sep; 22(5):211-5. PubMed ID: 9536540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biotyping of Propionibacterium acnes strains isolated from patients with acne vulgaris].
    Ergin C; Kaleli I; Sahin R; Ergin S; Kaçar N
    Mikrobiyol Bul; 2006; 40(1-2):15-21. PubMed ID: 16775952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acne and risk of prostate cancer.
    Sutcliffe S; Giovannucci E; Isaacs WB; Willett WC; Platz EA
    Int J Cancer; 2007 Dec; 121(12):2688-92. PubMed ID: 17724724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action.
    Pollock B; Turner D; Stringer MR; Bojar RA; Goulden V; Stables GI; Cunliffe WJ
    Br J Dermatol; 2004 Sep; 151(3):616-22. PubMed ID: 15377348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of topical erythromycin and oral tetracycline in acne vulgaris.
    Rapaport M; Puhvel SM; Reisner RM
    Cutis; 1982 Jul; 30(1):122-6, 130, 132-5. PubMed ID: 6214377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.